Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas
- 30 April 2010
- journal article
- Published by Elsevier BV in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 6 (2), 382-390
- https://doi.org/10.1016/j.nano.2009.10.001
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Role of Stat3 in suppressing anti-tumor immunityCurrent Opinion in Immunology, 2008
- A Novel Small Molecule Inhibitor of Signal Transducers and Activators of Transcription 3 Reverses Immune Tolerance in Malignant Glioma PatientsCancer Research, 2007
- Altered macrophage differentiation and immune dysfunction in tumor developmentJCI Insight, 2007
- QUANTUM DOTS ARE PHAGOCYTIZED BY MACROPHAGES AND COLOCALIZE WITH EXPERIMENTAL GLIOMASNeurosurgery, 2007
- Human Monocytes, but not Dendritic Cells Derived from Them, Are Defective in Base Excision Repair and Hypersensitive to Methylating AgentsCancer Research, 2007
- Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapyEuropean Journal of Cancer, 2006
- Fluorescent Nanoparticle Uptake for Brain Tumor VisualizationNeoplasia, 2006
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisCell, 2006
- Flow Cytometric Characterization of Tumor-associated Macrophages in Experimental GliomasNeurosurgery, 2000
- Immunohistological evaluation of macrophage infiltrates in brain tumorsJournal of Neurosurgery, 1988